Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: ADR120S, Inc.

Market Cap 7.27B 45.07M 39.29M 36.39M 34.07M 63.89M 4.25B 64.28M 432M 167M 2.09B 169M 166M P/E 2024
62.8x
P/E 2025 -3.35x
Enterprise Value 9.66B 59.9M 52.22M 48.37M 45.28M 84.92M 5.65B 85.43M 574M 222M 2.78B 225M 220M EV / Sales 2024
6.46x
EV / Sales 2025 78.3x
Free-Float
21.25%
Yield 2024 *
-
Yield 2025 -
03-31 ADR120S, Inc. cancelled the acquisition of 71.51% stake in AthleteMed Corporation from EBISTRADE Inc. CI
25-10-28 ADR120S, Inc. share transfer agreement to acquire 71.51% stake in AthleteMed Corporation from EBISTRADE Inc. CI
24-09-24 Samty Hotel Management K.K. agreed to acquire Fractal Hospitality Co., Ltd. from Cytori Cell Research Institute, Inc.. CI
24-03-12 Samty Hotel Management K.K. agreed to acquire Hotel Kanazawa Co., Ltd. from Cytori Cell Research Institute, Inc.. CI
23-05-12 Cytori Cell Research Institute,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
21-12-26 Sakurajyuji Co., Ltd. signed an agreement to acquire approximately 1.60% stake in FRACTALE Corporation (TSE : 3750) from Aqua Strategic Investment Business Limited Partnership, managed by ACA Inc. for approximately ¥200 million. CI
21-05-14 FRACTALE Corporation canceled the acquisition of Cytori Therapeutics inc from HG Capital, The Conscious Group Ltd, Toshiyasu Horie, Tokyo Weld Co., Ltd. and Capital Medica Co.Ltd. CI
21-01-12 FRACTALE Corporation announced that it has received ¥12.675 million in funding from Japan International Partners LLC CI
20-12-27 FRACTALE Corporation announced that it expects to receive ¥12.675 million in funding from Japan International Partners LLC CI
20-07-02 FRACTALE Corporation acquired 91% stake in Alegrox Hotel Management Co., Ltd from Shinji Ezure and others for ¥21.2 million. CI
20-05-14 FRACTALE Corporation agreed to acquire the remaining 43.63% stake in Cytori Therapeutics inc from HG Capital, The Conscious Group Ltd, Toshiyasu Horie, Tokyo Weld Co., Ltd. and Capital Medica Co.Ltd. for ¥2.1 billion. CI
20-02-24 Osaka Mokuzai Sougo Ichiba Co., Ltd. cancelled the acquisition of Ikeda Fudosan Co., Ltd. from FRACTALE Corporation. CI
19-04-24 Seijiro Shirahama and FRACTALE Corporation completed the acquisition of Cytori Therapeutics K.K. and Cell Therapy Assets in Japan. CI
1 day-0.13%
1 week-1.25%
Current month-1.25%
1 month-3.78%
3 months-11.24%
6 months-4.93%
Current year-5.95%
1 week 786
Extreme 786
800
1 month 782
Extreme 782
825
Current year 780
Extreme 780
890
1 year 730
Extreme 730
990
3 years 642
Extreme 642
1,284
5 years 642
Extreme 642
1,750
10 years 184.4
Extreme 184.4
1,841
Manager TitleAgeSince
President 69 2023-05-31
Investor Relations Contact 54 2019-10-31
Director TitleAgeSince
Director/Board Member 73 2024-12-31
Director/Board Member 56 2010-09-30
Chairman 69 2024-05-31
Date Insider Type Main position Quantity % Market Cap.
25-04-08Free 130,100 1.4570%
25-04-08Free 321,100 3.5960%
25-03-05Buy

Chairman

110,000 1.2319%
Change 5-day change 1-year change 3-year change Capi.($)
-0.13%-1.25%+6.04%-28.57% 43.74M
+0.58%-1.39%-1.75%+70.98% 38.52B
-3.93%-11.72%-17.17%-3.50% 17.18B
-0.34%-0.89%+24.67%+100.87% 13.79B
-0.21%-10.96%+3.02%-0.79% 11.31B
0.00%0.00%+0.79%-24.26% 9.9B
+0.74%+0.84%-51.23%-30.64% 7.37B
-1.02%-3.73%-18.80%+1.77% 6.25B
+0.50%-4.73%-26.72%+4.87% 4.68B
-1.77%-2.16%+0.35%+41.98% 4.66B
Average -0.56%-3.21%-8.08%+13.27% 11.37B
Weighted average by Cap. -0.52%-3.11%-5.26%+33.59%

Financials

2024 2025
Net sales 1.56B 9.67M 8.43M 7.81M 7.31M 13.71M 913M 13.8M 92.67M 35.91M 449M 36.31M 35.53M 122M 757K 660K 611K 572K 1.07M 71.38M 1.08M 7.25M 2.81M 35.14M 2.84M 2.78M
Net income 138M 856K 746K 691K 647K 1.21M 80.74M 1.22M 8.2M 3.18M 39.74M 3.21M 3.14M -2.14B -13.27M -11.57M -10.72M -10.03M -18.81M -1.25B -18.93M -127M -49.27M -616M -49.81M -48.74M
Net Debt 1.43B 8.89M 7.75M 7.18M 6.72M 12.6M 838M 12.67M 85.12M 32.99M 413M 33.35M 32.64M 2.39B 14.83M 12.93M 11.98M 11.21M 21.03M 1.4B 21.16M 142M 55.07M 689M 55.68M 54.48M
Logo ADR120S, Inc.
ADR120S Inc, formerly Cytori Cell Research Institute Inc, is a Japan-based company mainly engaged in investing in medical assets, buying and selling real estate, investing in real estate business projects, and managing its real estate holdings. The Company operates its business through two segments. The Medical Business segment is engaged in investments in regenerative medicine and other businesses. The Real Assets business segment is mainly engaged in real estate sales and purchase, investment in real estate business projects, and hotel business.
Employees
10
Date Price Change Volume
26-06-19 790.00 ¥ -0.13% 4,300
26-06-18 791.00 ¥ -0.88% 6,800
26-06-17 798.00 ¥ +0.88% 2,000
26-06-16 791.00 ¥ 0.00% 1,700
26-06-15 791.00 ¥ -1.12% 2,900

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 3750 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!